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Plasma concentrations of the D-dimer fragment were
measured.
Results: Fifteen patients (16.48%) had LAA thrombi
whereas 76(82.52%) patients had no evidenceof thrombi.
Patients with LA thrombus showed a significantly
higher D-dimer levels (965.67 ± 570.27 lg/L vs
261.20 ± 193.80 lg/L, P < 0.0001) and a significantly lower
mitral annular S wave velocity (10.7 ± 2.1 cm/s vs
15.2 ± 3.5 cm/s, P < 0.001) than those without LA
thrombi. The LAA emptying velocity showed a signifi-
cant positive correlation with the S wave velocity
(r = 0.884, P < 0.0001) and a significant negative correla-
tion with the D-dimer levels (r = 0.643, P < 0.0001).
Multivariable analysis revealed that the most powerful
predictors of LA thrombus were the plasma D-dimer
level (OR = 19.6, 95% CI = (1.25–308), P < 0.05) and the
S wave velocity (OR = 32.0, 95% CI = (2.1–490), P < 0.01).
ROC analysis yielded an optimal D-dimer cutoff value
of 423.25 lg/L for prediction of LAA thrombi with a sen-
sitivity of 85.7%, a specificity of 92.1%, a positive predic-
tive value of 66.7% and a negative predictive value of
95.9% while S wave of 12.5 cm/s predicted LA thrombus
with a sensitivity of 92.9%, a specificity of 78.1%, a posi-
tive predictive value of 86.5% and a negative predictive
value of 82.2%.
Conclusions: D-dimer and S wave velocity are inde-
pendent predictors of LAA thrombus in MS patients with
SR. The S wave velocity has a better positive predictive
value than the D-dimer which has a better negative pre-
dictive values.
http://dx.doi:10.1016/j.jsha.2013.03.105
The validity of a global tissue Doppler index in
estimating left ventricular end-diastolic pressure
in patients with coronary artery disease
Khalid Abd El Salam, Maha El Sebaie
Cardiology Department, Faculty of Medicine, Zagazig
University, Cairo, Egypt
Background: The left ventricular end diastolic pres-
sure (LVEDP) is an important parameter in cardiac
patients. There are few data on adding tissue Doppler
derived mitral annular peak systolic velocity (S0) wave
to the ratio of early mitral inflow to mitral annular veloc-
ity (E/E0) for the estimation of left ventricular end dia-
stolic pressure (LVEDP) in patients with preserved LV
ejection fraction. Objectives To assess the validity of E/
(E0Å  S0) in estimating LVEDP in patients with CAD
and intermediate E/E0.
Methods: Sixty-five subjects underwent echocardi-
ography and TDI of the mitral annulus in less than
30 min of cardiac catheterization. Echocardiographic vari-
ables including E/E0 and E/(E0Å  S0) were compared to
invasively measured LVEDP.
Results: Based on coronary angriography, 49 sub-
jects showed significant CAD (group I) while 16 subjects
showed no evidence of CAD (control group). The E/E0
and the E/(E0X S0) were significantly higher in CAD
patients than in the control group (P < 0.001). In patients
with intermediate E/E0, there was a highly significant
positive correlation between the E/(Ex S0) and LVEDP
(r = 0.785, P < 0.0001) while the E/E0 showed no significant
correlation with the LVEDP in this subset of patients
(r = 0.274, P > 0.05). ROC analysis yielded an optimal E/
(E0Å  S0) cutoff value of 1.43 for prediction of LVEDP
>12 mmHg with a sensitivity of 90.9%, a specificity of
57.1%, a positive predictive value of 76.9% and a negative
predictive value of 80.0% (AUC 0.88, 95% CI 0.71–1.00,
P < 0.05). The E/E’ ROC cutoff value of 12.2 predicted
LVEDP >12 mmHg with a sensitivity of 72.7%, a specific-
ity of 28.6%, a positive predictive value of 61.5% and a
negative predictive value of 40.0% (AUC 0.68, 95% CI
0.44–0.93, P > 0.05).
Conclusions: E/(E0Å  S0) correlates well with
LVEDP and can be used as a simple andaccurate estimate
ofLVEDP in coronary artery disease patients with inter-
mediate E/E0.
http://dx.doi:10.1016/j.jsha.2013.03.106
Genetic thrombophilia in patients with ischemic
heart disease
Mahmoud Yossouf, Solaf El Sharawy, Salah Aref
Hanan Glal, Wael Elkhiary
Introduction: In premature IHD, the role of genetic
risk factors should be more important than environmen-
tal factors. Genetic thrombophilias represent a group of
inherited conditions that predispose to thrombosis.
Although the association between inherited thrombo-
philia and some thrombotic diseases as deep venous
thrombosis is well-established, controversial data are
present on the association between inherited thrombo-
philia and IHD.
The aim of the study: To study some genetic
thrombophilic variants in patients suffering from ische-
mic heart disease.
Subjects and methods: 72 subjects: 52 patients with
premature ischemic heart disease <40 years. classified
into:  Acute M.I. group:(31 patients).  Unstable angina
group: (21 patients), and 20 apparently healthy individu-
als (of matched age and sex as a control group History
taking, clinical and E.C.G. and laboratory investigations
(cardiac markers, lipogram, lupus anticoagulants screen-
ing, antiphospholipids IgG/lgM and anticardiolipin IgG/
lgM antibodies). Also, samples were taken for DNA
extraction and typing with cardiovascular disease
(CVD) StripAssay for the identification of mutations
associated with CVD based on polymerase chain reaction
(PCR) and reverse-hybridization molecular technique.
The assay covers 12 polymorphisms.
Results: \In UA patients group, the heterozygous
(GA) genotype, and the (A) for UA, compared with
the control group In addition, there were significant
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decreases in the frequencies of heterozygous (GT), and
T allele of FXIII Val34Leu in UA patients group, com-
pared with the control group assuming a protective role
of FXIII 34Leu allele against unstable angina develop-
ment. The prevalence of other studied polymorphisms;
factor V H1299R (R2), Glycoprotein IIIa Leu33Pro,PAI-1
4G/5G, MTHFR C677T polymorphisms, MTHFR
A1298C, apo B R3500Q and apo E polymorphisms; did
not differ between IHD patients and control subjects.
There was a significant positive association between
FVL and family history of IHD in AMI patients. In addi-
tion, a highest prevalence of Pl A2 in patients <35 years
of age surviving a first AMI, so that age-at-onset of AMI
was significantly affected by PlA2 (<35 years vs. 35–40).
Apo E3/E4 genotype was associated with both high total
Cholesterol (TC) and high TC/HDL ratio in UA group,
while in AMI patients, Apo E3/E4 genotype was associ-
ated with high TC/HDL ratio, and high triglycerides
levels.
Conclusions: This study has identified a positive
association for FV Leiden, Prothrombin G20210A hetero-
zygosity, and ACE (I/D) polymorphism with premature
AMI; a positive association for b-fibrinogen 455-GA poly-
morphism in UA patients; and a negative association
(protective role) for FXIII Val34Leu in UA patients. This
study may open a dooor to promised goals of new thera-
peutics and personalised medicine for premature IHD
based on single nucleotide polymorphism in well defined
groups of high risk patients (<40 years); and their
families.
http://dx.doi:10.1016/j.jsha.2013.03.107
Intrauterine first-line therapy and outcome of fetal
heterotopic tachycardia
Marouane Boukhris, Kaouathar Hakim,
Nidhal Ben Moussa, Hela M’saad, Fatma Ouarda,
Rafik Boussaada
Background: Fetal heterotopic tachycardia is associ-
ated with a high risk of congestive heart failure, fetal
hydrops and intrauterine death. Transplacental treat-
ment by antiarrhythmic agents can improve prognosis
dramatically.
Objectives: The aim of our study is to review the
management and the outcome of heterotopic tachycardia
in fetal patients treated in our center.
Methods: We reported 24 cases of heterotopic fetal
tachycardia diagnosed and treated mainly with digoxin
and/or amiodarone administered by the transplacental
way.
Results: Twenty four fetal patients were studied,
thirteen with supraventricular tachycardia, eight with
atrial flutter and three with chaotic atrial tachycardia.
Among them, eight fetuses were hydropic. All mothers
were given an antiarrythmic treatment by mouth. There
were three intrauterine deaths. Digoxin monotherapy
converted 6/8 non hydropic fetuses and 0/2 hydropic
fetuses who died. Amiodarone monotherapy converted
4/6 including 2 hydropic fetuses with one intrauterine
death. The association of digoxin and amiodarone con-
verted 7/7 fetuse including 3 hydropic patients. No death
found with this association. Propanolol was used in
monotherapy or associated with digoxin in vain in three
patients with chaotic atrial tachycardia.
Conclusions: Maternal oral antiarrhythmic treat-
ment should be given as soon as the diagnosis of fetal
heterotopic tachycardia is done. Digoxin and amiodarone
seems to be effective. Their association is particularly
indicated in hydropic fetuses.
http://dx.doi:10.1016/j.jsha.2013.03.108
Successful transcatheter closure of perimembra-
nous ventricular septal defect with inlet extension
using Amplatzer occlude device (ADOI)
Mashail Alobaidan, Abdulmajeed Alotay,
Nabeel Abdulrazaaq
Introduction: Transcatheter closure of perimembra-
nous ventricular septal defect (PM VSD) is abandoned in
many center and in some became restricted to certain age
and criteria because of the risk of complete heart block
(CHB). The risk of damaging the tricuspid valve (TV) in
the presence of inlet extension is another risk. I am pre-
senting successful closure of such defect using Amplatzer
occluder device for PDA with reasonable follow up per-
iod in Prince Sultan Cardiac Center PSCC.
Method: Through 2011 4 patients underwent trans-
catheter closure of PM VSD with inlet extension, all
patients were consented and procedure were done under
general anesthesia, Transesophageal echocardiography
was done in all, one has 3D assessment Hemodynamics
were assessed pre procedural, A–V loop was applied in
2 patients, ADOI were used in all,heparin and antibiotics
were giving during and 24 h post procedure, 3 patients
were extubated same day and one the following day, all
patients were kept on aspirin for 6 months.
Result: Median age 17 kg, 3 female and 1 male, med-
ian age 7 year, Median ventilatory duration is one day,
Median hospital stay is 2 days, Median Follow up is 16
months, No immediate or early complication or deaths,
normal ECG immediately and during follow up period,
normal Echocardiography with no residual leak during
follow up period.
Conclusion: In selected patients with PM VSD and
inlet extension ADOI device can be used safely and effec-
tively to close the defect with no immediate or early
complications.
http://dx.doi:10.1016/j.jsha.2013.03.109
Early experience on aortic arch surgery at King
Fahd Armed Forced Hospital (KFAFH), Jeddah
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